• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IVERIC bio, Inc. - Common Stock (NQ:ISEE)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 10, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 39.94 (50)
Ask (Size) 39.95 (15)
Prev. Close 39.95
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 104,009,398
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 ↗
December 29, 2023
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.  
Via Benzinga
News headline image
From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs ↗
July 07, 2023
Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as... 
Via Benzinga

Performance

More News

Read More
IVERIC bio Inc. (NASDAQ: ISEE) Records 52-Week High Thursday Morning
July 06, 2023
Via Investor Brand Network
IVERIC bio Inc. (NASDAQ: ISEE) Making Surprising Moves in Monday Session
June 05, 2023
Via Investor Brand Network
News headline image
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 05, 2023
From IVERIC bio, Inc.
Via Business Wire
News headline image
IVERIC BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. - ISEE
June 14, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 02, 2023
From IVERIC bio, Inc.
Via Business Wire
News headline image
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree ↗
June 02, 2023
Via Investor's Business Daily
Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?
June 01, 2023
Via TheNewswire.com
News headline image
Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?
June 01, 2023
Via News Direct
News headline image
Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition? ↗
May 30, 2023
Via Benzinga
News headline image
Why Shares of Annexon Are Plummeting Thursday ↗
May 25, 2023
Via The Motley Fool
News headline image
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 24, 2023
From IVERIC bio, Inc.
Via Business Wire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
May 08, 2023
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023 ↗
May 04, 2023
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2023 ↗
May 03, 2023
Via Benzinga
News headline image
IVERIC BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. - ISEE
May 02, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023 ↗
May 02, 2023
Via Benzinga
News headline image
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today ↗
May 01, 2023
Via The Motley Fool
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq – ISEE), Midwest Holding Inc. (Nasdaq – MDWT), Hoth Therapeutics, Inc. (Nasdaq – HOTH)
May 01, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023 ↗
May 01, 2023
Via Benzinga
News headline image
Biotech Buying Bonanza: Iveric Bio Snags $5.9 Billion Deal From Astellas Pharma ↗
May 01, 2023
Via Investor's Business Daily
News headline image
First Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top Stories ↗
May 01, 2023
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
May 01, 2023
Via Benzinga
News headline image
Nasdaq, S&P 500 Futures On Edge Over First Republic Failure, Tech Earnings: Analyst Pins Hopes On Fed's Next Move ↗
May 01, 2023
Via Benzinga

Frequently Asked Questions

Is IVERIC bio, Inc. - Common Stock publicly traded?
Yes, IVERIC bio, Inc. - Common Stock is publicly traded.
What exchange does IVERIC bio, Inc. - Common Stock trade on?
IVERIC bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for IVERIC bio, Inc. - Common Stock?
The ticker symbol for IVERIC bio, Inc. - Common Stock is ISEE on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap